银屑病皮肤炎症、全身炎症与心血管疾病的关联研究
该研究基于PACI横断面研究和SPC队列研究,探讨全身炎症是否介导银屑病皮肤严重程度与心血管疾病的关联。结果发现PASI与GlycA水平及CVD相关,GlycA与CVD相关,PASI对CVD的间接效应经GlycA介导,提示全身炎症可能是介导因素。
要点
- PASI评估的银屑病皮肤严重程度与全身炎症标志物GlycA水平相关。
- PASI和GlycA均与心血管疾病(CVD)相关。
- 全身炎症可能介导PASI与CVD之间的关联。
核心结论
- PASI评估的皮肤严重程度与全身炎症相关,PASI和GlycA均与CVD相关,全身炎症可能介导PASI与CVD的关联。
主要发现
- 在两项研究中,PASI与GlycA水平和CVD相关,GlycA水平与CVD相关。
- PASI对NCB的直接效应为0.94(95% CI,0.26-1.74),经GlycA的间接效应为0.19(95% CI,0.02-0.47)。
- PASI对心血管事件的直接效应OR为1.23(95% CI,0.70-1.92),间接效应OR为1.16(95% CI,1.04-1.42)。
临床怎么用
- 临床评估银屑病患者时,应考虑皮肤严重程度与全身炎症及心血管风险的关联,可能需监测全身炎症标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Psoriasis is associated with increased cardiovascular risk, but the underlying pathogenic mechanisms remain unclear. Elucidating these mechanisms can help develop treatment strategies and enhance understanding of the link between peripheral inflammation, such as psoriatic skin lesions, and cardiovascular disease (CVD). OBJECTIVE: To explore whether systemic inflammation is a mediator of the association between psoriasis skin disease severity and CVD. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from cross-sectional study (Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative [PACI]), which enrolled patients from January 2013 to February 2022, and an inception cohort study (Stockholm Psoriasis Cohort [SPC]), which enrolled patients from January 2000 to December 2005. The PACI enrolled consecutive patients referred by dermatologists in Maryland, and the SPC enrolled consecutive patients referred from a wide range of practices in Sweden. Patients with prevalent psoriasis from the PACI and patients with incident psoriasis from the SPC were included. Data were analyzed from October 2023 to January 2024. EXPOSURES: Psoriasis skin disease severity was measured using the Psoriasis Area and Severity Index (PASI), and systemic inflammation was measured using glycan biomarker of N-acetyl side chains of acute-phase proteins (GlycA). Mediation analysis was performed by evaluating the associations between exposure, mediator, and outcome in patients with first-tertile and third-tertile PASI scores when GlycA level was set at the level observed in patients with first-tertile PASI. MAIN OUTCOMES AND MEASURES: Noncalcified coronary burden (NCB) measured using coronary computed tomography angiography in the PACI and hospitalization for CVD or cardiovascular death in the SPC. RESULTS: Of 260 eligible patients from the PACI, 162 (62.3%) were male, and the median (IQR) age was 51 (41-60) years; of 509 eligible patients from the SPC, 237 (46.6%) were male, and the median (IQR) age was 43 (30-57) years. In both studies, PASI was associated with GlycA level and CVD, and GlycA level was associated with CVD. The direct and indirect (through GlycA) effects of PASI on NCB were estimated at 0.94 (95% CI, 0.26-1.74) and 0.19 (95% CI, 0.02-0.47), respectively. The odds ratios for the direct and indirect effects of PASI on cardiovascular events were estimated at 1.23 (95% CI, 0.70-1.92) and 1.16 (95% CI, 1.04-1.42), respectively. CONCLUSIONS AND RELEVANCE: In this study, skin disease severity measured using PASI was associated with systemic inflammation, and both PASI and systemic inflammation, measured using GlycA levels, were associated with CVD. The association between PASI and CVD may be mediated by systemic inflammation.
引用
- Svedbom A, Mallbris L, González-Cantero Á, et al. Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis. JAMA Dermatol. 2025. PMID: 39565616. doi:10.1001/jamadermatol.2024.4433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。